Results 21 to 30 of about 229,062 (265)

Radioimmunotherapy: A novel treatment of non-Hodgkin lymphoma [PDF]

open access: yesArchive of Oncology, 2010
90Y-ibritumomab tiuxetan (Zevalin) and 131I-tositumomab (Bexxar) are current choices for radioimmunotherapy (RIT) of patients with follicular rituximab-relapsed or refractory CD20+ follicular B-cell NHL.
Petrović Tomislav, Mihailović Jasna
doaj   +1 more source

Iodine Behaviour During a Severe Accident in a Nuclear Power Plant

open access: yesCHIMIA, 2005
Iodine is a main fission product of the fuel generated during power operation in nuclear power plants (NPPs). A severe NPP accident can cause fuel, containing fission products (FPs), control rod assemblies and core structures to melt and then ...
Salih Guentay   +3 more
doaj   +1 more source

The effect of exposure on cattle thyroid after the Fukushima Daiichi nuclear power plant accident

open access: yesScientific Reports, 2022
Nuclear plant accidents can be a risk for thyroid cancer due to iodine radioisotopes. Near the Fukushima Daiichi nuclear power plant, cattle were exposed to radiation after the accident occurred in May 2011. Here we estimated the total radiation exposure
Daiki Horikami   +12 more
doaj   +1 more source

From prophylaxis to atomic cocktail : circulation of radioiodine [PDF]

open access: yes, 2009
This paper is a history of iodine. To trace the trajectory of this element, goiter is used as a guideline for the articulation of a historical account, as a representation of thyroid disorders and of the spaces of knowledge and practices related to ...
Santesmases, María Jesús
core   +3 more sources

Efficiency of 124I radioisotope production from natural and enriched tellurium dioxide using 124Te(p,xn)124I reaction

open access: yesEJNMMI Physics, 2022
Background 124I Iodine (T $$_{1/2}$$ 1 / 2 = 4.18 d) is the only long-life positron emitter radioisotope of iodine that may be used for both imaging and therapy as well as for 131I dosimetry.
Paweł Bzowski   +9 more
doaj   +1 more source

TSHOMA: A RARE PITUITARY TUMOR

open access: yesKhyber Medical University Journal, 2021
INTRODUCTION: TSH-secreting pituitary adenomas (TSHoma) or thyrotropinoma are rare pituitary tumors that secrete an abnormal Thyroid Stimulating Hormone (TSH) which constitutes up to 1%–2% of all pituitary adenomas. Patients often remain misdiagnosed for
Muhammad Salman Aamir   +5 more
doaj   +1 more source

Radioactive seed migration after prostate brachytherapy with Iodine-125 using loose seeds versus stranded seeds

open access: yesInternational Brazilian Journal of Urology, 2009
Objectives: To assess the incidence and clinical parameters that could influence migration of seeds in localized prostate cancer patients treated by stranded versus loose sources by Iodine-125 brachytherapy.
Carlos A. S. Franca   +4 more
doaj   +1 more source

Absorption of radionuclides from the Fukushima nuclear accident by a novel algal strain. [PDF]

open access: yesPLoS ONE, 2012
Large quantities of radionuclides have leaked from the Fukushima Daiichi Nuclear Power Plant into the surrounding environment. Effective prevention of health hazards resulting from radiation exposure will require the development of efficient and ...
Hiroki Shimura   +10 more
doaj   +1 more source

Korean-specific iodine S values for use in internal dosimetry

open access: yesNuclear Engineering and Technology, 2023
The use of iodine S values derived using the International Commission Radiological Protection (ICRP) phantoms may introduce significant bias in internal dosimetry for Koreans due to anatomical variability.
Tae-Eun Kwon   +2 more
doaj  

POSTOPERATIVE RELATIONSHIP BETWEEN CELLULAR IMMUNE STATUS AND CLINICOPATHOLOGICAL CHARACTERISTICS IN DIFFERENTIATED THYROID CANCER PRIOR TO 131I THERAPY [PDF]

open access: yes精准医学杂志, 2023
Objective To investigate the postoperative relationship between cellular immune status and clinicopathological features in patients with differentiated thyroid carcinoma (DTC) before 131I therapy. Methods We retrospectively included 155 patients with DTC
LU Chenghui, LI Jiao, LIU Xinfeng, WANG Guoqiang, WANG Zenghua, ZHANG Yingying, HAN Na, SI Zengmei, WANG Xufu
doaj   +1 more source

Home - About - Disclaimer - Privacy